CRISPR

CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes and provide a form of acquired immunity. CRISPR is found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms.

Read more in the app

Using CRISPR to detect cancer biomarkers

CRISPR technology: A decade of genome editing is only the beginning

How CRISPR is making farmed animals bigger, stronger, and healthier

Modified CRISPR-based enzymes improve the prospect of inserting entire genes into the genome to overcome diverse disease-causing mutations

How a CRISPR protein might yield new tests for many viruses

Crispr’s Quest to Slay Donegal Amy

The Crispr Baby Scientist Is Back. Here’s What He’s Doing Next

By using CRISPR to edit a flowering repressor gene, scientists have developed a method to allow trees to flower in mere months.

CRISPR gene-editing may boost cancer immunotherapy, new study finds

Alzheimer’s disease progression slowed using CRISPR technique in mice

A teen's cancer is in remission after she received new cells edited with CRISPR

CRISPR technology improves Huntington's disease symptoms in models

Experimental CRISPR technique has promise against aggressive leukaemia

CRISPR insight: How to fine-tune the Cas protein's grip on DNA

CRISPR is so popular even viruses may use it

Genetic 'hitchhikers' can be directed using CRISPR

CRISPR’s ‘ancestry problem’ misses cancer targets in those of African descent

Groundbreaking CRISPR treatment for blindness only works for subset of patients

In First, Scientists Use CRISPR for Personalized Cancer Treatment

This Personalized Crispr Therapy Is Designed to Attack Tumors